Annual Cash & Cash Equivalents
$4.33 M
-$33.74 M-88.63%
31 December 2023
Summary:
TherapeuticsMD annual cash & cash equivalents is currently $4.33 million, with the most recent change of -$33.74 million (-88.63%) on 31 December 2023. During the last 3 years, it has fallen by -$76.16 million (-94.62%). TXMD annual cash & cash equivalents is now -97.32% below its all-time high of $161.61 million, reached on 31 December 2018.TXMD Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$5.05 M
-$185.00 K-3.54%
30 September 2024
Summary:
TherapeuticsMD quarterly cash and cash equivalents is currently $5.05 million, with the most recent change of -$185.00 thousand (-3.54%) on 30 September 2024. Over the past year, it has dropped by -$5.12 million (-50.35%). TXMD quarterly cash and cash equivalents is now -97.34% below its all-time high of $190.00 million, reached on 30 September 2018.TXMD Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TXMD Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -88.6% | -50.4% |
| 3 y3 years | -94.6% | -95.2% |
| 5 y5 years | -97.3% | -96.8% |
TXMD Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -94.6% | at low | -95.2% | +16.6% |
| 5 y | 5 years | -97.3% | at low | -97.0% | +16.6% |
| alltime | all time | -97.3% | -97.3% | >+9999.0% |
TherapeuticsMD Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $5.05 M(-3.5%) |
| June 2024 | - | $5.23 M(+20.6%) |
| Mar 2024 | - | $4.34 M(+0.3%) |
| Dec 2023 | $4.33 M(-88.6%) | $4.33 M(-57.4%) |
| Sept 2023 | - | $10.17 M(-26.0%) |
| June 2023 | - | $13.73 M(-20.4%) |
| Mar 2023 | - | $17.25 M(-54.7%) |
| Dec 2022 | $38.07 M(-41.4%) | $38.07 M(+40.6%) |
| Sept 2022 | - | $27.08 M(+3.0%) |
| June 2022 | - | $26.30 M(-13.4%) |
| Mar 2022 | - | $30.38 M(-53.2%) |
| Dec 2021 | $64.91 M(-19.4%) | $64.91 M(-38.1%) |
| Sept 2021 | - | $104.84 M(-5.9%) |
| June 2021 | - | $111.42 M(-19.0%) |
| Mar 2021 | - | $137.62 M(+71.0%) |
| Dec 2020 | $80.49 M(-50.0%) | $80.49 M(+1.1%) |
| Sept 2020 | - | $79.63 M(-30.0%) |
| June 2020 | - | $113.84 M(-33.1%) |
| Mar 2020 | - | $170.10 M(+5.8%) |
| Dec 2019 | $160.83 M(-0.5%) | $160.83 M(+3.5%) |
| Sept 2019 | - | $155.33 M(-15.0%) |
| June 2019 | - | $182.85 M(+48.8%) |
| Mar 2019 | - | $122.88 M(-24.0%) |
| Dec 2018 | $161.61 M(+27.1%) | $161.61 M(-14.9%) |
| Sept 2018 | - | $190.00 M(+23.1%) |
| June 2018 | - | $154.39 M(+43.8%) |
| Mar 2018 | - | $107.35 M(-15.6%) |
| Dec 2017 | $127.14 M(-3.3%) | $127.14 M(-14.3%) |
| Sept 2017 | - | $148.29 M(+53.7%) |
| June 2017 | - | $96.48 M(-15.0%) |
| Mar 2017 | - | $113.53 M(-13.7%) |
| Dec 2016 | $131.53 M(+103.3%) | $131.53 M(-10.8%) |
| Sept 2016 | - | $147.53 M(-11.4%) |
| June 2016 | - | $166.53 M(-8.5%) |
| Mar 2016 | - | $182.10 M(+181.4%) |
| Dec 2015 | $64.71 M(+26.0%) | $64.71 M(-20.2%) |
| Sept 2015 | - | $81.12 M(+20.6%) |
| June 2015 | - | $67.25 M(-26.6%) |
| Mar 2015 | - | $91.66 M(+78.5%) |
| Dec 2014 | $51.36 M(-5.2%) | $51.36 M(-23.3%) |
| Sept 2014 | - | $67.00 M(+88.4%) |
| June 2014 | - | $35.55 M(-21.7%) |
| Mar 2014 | - | $45.40 M(-16.2%) |
| Dec 2013 | $54.19 M(+3388.3%) | $54.19 M(-9.0%) |
| Sept 2013 | - | $59.57 M(+73.0%) |
| June 2013 | - | $34.44 M(-11.2%) |
| Mar 2013 | - | $38.78 M(+2396.3%) |
| Dec 2012 | $1.55 M(+1129.0%) | $1.55 M(+907.5%) |
| Sept 2012 | - | $154.20 K(-91.1%) |
| June 2012 | - | $1.73 M(+785.1%) |
| Mar 2012 | - | $195.20 K(+54.4%) |
| Dec 2011 | $126.40 K | $126.40 K(+2909.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2011 | - | $4200.00(+20.0%) |
| June 2011 | - | $3500.00(+250.0%) |
| Mar 2011 | - | $1000.00(-99.8%) |
| Dec 2010 | $422.90 K(+904.5%) | $422.90 K(+1669.5%) |
| Sept 2010 | - | $23.90 K(+545.9%) |
| June 2010 | - | $3700.00(-92.3%) |
| Mar 2010 | - | $48.00 K(+14.0%) |
| Dec 2009 | $42.10 K(-22.6%) | $42.10 K(+112.6%) |
| Sept 2009 | - | $19.80 K(+144.4%) |
| June 2009 | - | $8100.00(-71.1%) |
| Mar 2009 | - | $28.00 K(-48.5%) |
| Dec 2008 | $54.40 K(-86.7%) | $54.40 K(-14.9%) |
| Sept 2008 | - | $63.90 K(-47.5%) |
| June 2008 | - | $121.60 K(-66.3%) |
| Mar 2008 | - | $361.00 K(-11.6%) |
| Dec 2007 | $408.60 K(-58.5%) | $408.60 K(-63.8%) |
| Sept 2007 | - | $1.13 M(+7.4%) |
| June 2007 | - | $1.05 M(+3.0%) |
| Mar 2007 | - | $1.02 M(+3.5%) |
| Dec 2006 | $985.70 K(+9.2%) | $985.70 K(-3.2%) |
| Sept 2006 | - | $1.02 M(+30.9%) |
| June 2006 | - | $778.30 K(+16.0%) |
| Mar 2006 | - | $671.20 K(-25.6%) |
| Dec 2005 | $902.30 K(+250.1%) | $902.30 K(+72.3%) |
| Sept 2005 | - | $523.60 K(+25.1%) |
| June 2005 | - | $418.40 K(+13.6%) |
| Mar 2005 | - | $368.40 K(+43.0%) |
| Dec 2004 | $257.70 K(+66.8%) | $257.70 K(+217.4%) |
| Sept 2004 | - | $81.20 K(-68.3%) |
| June 2004 | - | $256.30 K(+11.4%) |
| Mar 2004 | - | $230.00 K(+48.9%) |
| Dec 2003 | $154.50 K(-51.2%) | $154.50 K(-41.3%) |
| Sept 2003 | - | $263.10 K(+15.1%) |
| June 2003 | - | $228.50 K(-22.5%) |
| Mar 2003 | - | $294.70 K(-6.9%) |
| Dec 2002 | $316.50 K(-6.6%) | $316.50 K(+18.5%) |
| Sept 2002 | - | $267.10 K(+8.0%) |
| June 2002 | - | $247.30 K(-34.6%) |
| Mar 2002 | - | $378.40 K(+11.7%) |
| Dec 2001 | $338.90 K(+76.9%) | $338.90 K(+25.9%) |
| Sept 2001 | - | $269.20 K(-8.2%) |
| June 2001 | - | $293.30 K(+22.9%) |
| Mar 2001 | - | $238.70 K(+24.6%) |
| Dec 2000 | $191.60 K(+232.1%) | $191.60 K(+36.7%) |
| Sept 2000 | - | $140.20 K(+42.0%) |
| June 2000 | - | $98.70 K(+23.2%) |
| Mar 2000 | - | $80.10 K(+38.8%) |
| Dec 1999 | $57.70 K(+303.5%) | $57.70 K |
| Dec 1998 | $14.30 K(-91.4%) | - |
| Dec 1997 | $166.90 K(-9.6%) | - |
| Dec 1996 | $184.60 K(>+9900.0%) | - |
| Dec 1995 | $0.00(-100.0%) | - |
| Dec 1994 | $19.40 K | - |
FAQ
- What is TherapeuticsMD annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for TherapeuticsMD?
- What is TherapeuticsMD annual cash & cash equivalents year-on-year change?
- What is TherapeuticsMD quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for TherapeuticsMD?
- What is TherapeuticsMD quarterly cash and cash equivalents year-on-year change?
What is TherapeuticsMD annual cash & cash equivalents?
The current annual cash & cash equivalents of TXMD is $4.33 M
What is the all time high annual cash & cash equivalents for TherapeuticsMD?
TherapeuticsMD all-time high annual cash & cash equivalents is $161.61 M
What is TherapeuticsMD annual cash & cash equivalents year-on-year change?
Over the past year, TXMD annual cash & cash equivalents has changed by -$33.74 M (-88.63%)
What is TherapeuticsMD quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of TXMD is $5.05 M
What is the all time high quarterly cash and cash equivalents for TherapeuticsMD?
TherapeuticsMD all-time high quarterly cash and cash equivalents is $190.00 M
What is TherapeuticsMD quarterly cash and cash equivalents year-on-year change?
Over the past year, TXMD quarterly cash and cash equivalents has changed by -$5.12 M (-50.35%)